Literature DB >> 176470

Cell killing by simian virus 40: variation in the pattern of lysosomal enzyme release, cellular enzyme release, and cell death during productive infection of normal and simian virus 40-transformed simian cell lines.

L C Norkin, J Ouellette.   

Abstract

Simian virus 40 (SV40) growth on rhesus kidney cells and on the T-22 line of SV40-transformed green monkey kidney (GMK) cells is largely limited by the low plating efficiency of SV40 on these cells. In addition, a fraction of the rhesus kidney and T-22 cells are resistant to infection by SV40. Nevertheless, 72-h viral yields per infected rhesus kidney and T-22 cell are nearly equivalent to that obtained on normal GMK cells and are independent of the multiplicity of infection. Despite the production of high viral yields, infected rhesus kidney and T-22 cells are killed slowly by SV40. Monolayers of these cells are also refractory to plaque formation by SV40. SV40 induces the release of lysosomal N-acetyl-beta-glucosaminidase into the cytoplasmic fractions of rhesus kidney and T-22 cells to an extent equal to that observed during infection of rapidly killed normal GMK cells. In contrast, damage to the plasma membrane, as indicated by the release of the cellular enzymes lactic dehydrogenase and glutamic oxaloacetic transaminase into the overlay media, occurred to a much greater extent in the normal GMK cells than in the rhesus kidney or T-22 cells. Neither a lysosomal hydrolase mechanism nor viral release appear to be responsible for this phenomenon. The different rates and extents of the SV40 cytocidal process on these cells do not result from the differences in the viral plating efficiency on them.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 176470      PMCID: PMC515520     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

1.  Inhibition of glycosidases by aldonolactones of corresponding configuration. 2. Inhibitors of beta-N-acetylglucosaminidase.

Authors:  J FINDLAY; G A LEVVY; C A MARSH
Journal:  Biochem J       Date:  1958-07       Impact factor: 3.857

2.  Variation in properties of SV40-transformed simian cell lines detected by superinfection with SV40 and human adenoviruses.

Authors:  J S Butel; L S Richardson; J L Melnick
Journal:  Virology       Date:  1971-12       Impact factor: 3.616

3.  Transformation of green monkey kidney cells by SV40 genome: the establishment of transformed cell lines and the replication of human adenoviruses and SV40 in transformed cells.

Authors:  K Shiroki; H Shimojo
Journal:  Virology       Date:  1971-07       Impact factor: 3.616

4.  Superinfection of simian virus 40-transformed permissive cells with simian virus 40.

Authors:  G Barbanti-Brodano; P Swetly; H Koprowski
Journal:  J Virol       Date:  1970-11       Impact factor: 5.103

5.  Patterns of cytopathology and lysosomal enzyme release in poliovirus-infected HEp-2 cells treated with either 2-(alpha-hydroxybenzyl)-benzimidazole or guanidine HCl.

Authors:  L E Guskey; P C Smith; D A Wolff
Journal:  J Gen Virol       Date:  1970-01       Impact factor: 3.891

6.  An autoradiographic screening test for mycoplasmal contamination of mammalian cell cultures.

Authors:  G P Studzinski; J F Gierthy; J J Cholon
Journal:  In Vitro       Date:  1973 May-Jun

7.  Newcastle disease virus-induced plasma membrane damage.

Authors:  J Katzman; D E Wilson
Journal:  J Gen Virol       Date:  1974-07       Impact factor: 3.891

8.  Studies on the mechanism of vaccinia virus cytopathic effects: effect of inhibutors of RNA and protein synthesis on early virus-induced cell damage.

Authors:  R Bablanian
Journal:  J Gen Virol       Date:  1970-02       Impact factor: 3.891

9.  Mengovirus-induced cytopathic effect in L-cells: protective effect of interferon.

Authors:  A T Haase; H Levy; S Baron; J A Kasel
Journal:  J Virol       Date:  1969-10       Impact factor: 5.103

10.  Lysosomes in lymphoid tissue. I. The measurement of hydrolytic activities in whole homogenates.

Authors:  W E Bowers; J T Finkenstaedt; C de Duve
Journal:  J Cell Biol       Date:  1967-02       Impact factor: 10.539

View more
  16 in total

1.  Permeability changes of plasma and lysosomal membranes in HeLa cells infected with rabbit poxvirus.

Authors:  D Schümperli; E Peterhans; R Wyler
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

2.  Modification of simian virus 40 protein A.

Authors:  P Tegtmeyer; K Rundell; J K Collins
Journal:  J Virol       Date:  1977-02       Impact factor: 5.103

3.  Effect of input multiplicity on the establishment of simian virus 40 persistent infections in rhesus monkey kidney cells.

Authors:  L C Norkin
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

4.  Cell killing by Simian virus 40: protective effect of chloroquine.

Authors:  L C Norkin; K H Einck
Journal:  Antimicrob Agents Chemother       Date:  1978-12       Impact factor: 5.191

5.  Human glioblastoma cells persistently infected with simian virus 40 carry nondefective episomal viral DNA and acquire the transformed phenotype and numerous chromosomal abnormalities.

Authors:  L C Norkin; V I Steinberg; M Kosz-Vnenchak
Journal:  J Virol       Date:  1985-02       Impact factor: 5.103

Review 6.  Papovaviral persistent infections.

Authors:  L C Norkin
Journal:  Microbiol Rev       Date:  1982-12

7.  Class I major histocompatibility proteins as cell surface receptors for simian virus 40.

Authors:  W J Atwood; L C Norkin
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

8.  Release of simian virus 40 virions from epithelial cells is polarized and occurs without cell lysis.

Authors:  E T Clayson; L V Brando; R W Compans
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

9.  The agnogene of the human polyomavirus BK is expressed.

Authors:  C H Rinaldo; T Traavik; A Hey
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

10.  Cell killing by simian virus 40: impairment of membrane formation and function.

Authors:  L C Norkin
Journal:  J Virol       Date:  1977-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.